Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma
- 12 April 2005
- journal article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 59 (5) , 537-543
Abstract
In this study, we aimed to investigate the clinicopathological characteristics with special emphasis on c-kit expression and the treatment results of patients with extrapulmonary small cell carcinoma (EPSCC). The medical records of the patients with EPSCC were reviewed, and the data regarding patient and tumour characteristics, treatment and clinical outcome were retrieved and analysed. A total of 28 patients with the diagnosis of EPSCC were identified. There were 19 males and 9 females, with a mean age of 56.5 years. Patients with limited disease (LD) (n = 13) were treated with surgery, chemotherapy (CT) and radiotherapy with different sequences. Patients with extensive disease (ED) (n = 15) were mainly treated with combination CT. The median overall survival was 14.5 months in patients with LD compared to 11 months in those with ED (p = 0.029). Ten patients (36%) showed c-kit overexpression. There was no significant difference between the survival of c-kit-positive and c-kit-negative patients (p = 0.367). In conclusion, our study demonstrates that the prognosis of EPSCC is poor despite currently available treatments. C-kit may be considered as a potential target for novel therapeutical approaches.Keywords
This publication has 32 references indexed in Scilit:
- The role of new targeted therapies in small-cell lung cancerCritical Reviews in Oncology/Hematology, 2004
- Expression and Mutational Status of c-kit in Small-Cell Lung CancerClinical Cancer Research, 2004
- Overexpression of c-kit protein is an infrequent event in small cell carcinomas of the uterine cervixLaboratory Investigation, 2004
- Extrapulmonary Small-cell Carcinoma: a Single-institution ExperienceJapanese Journal of Clinical Oncology, 2004
- Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 casesBritish Journal of Cancer, 2004
- Expression of the tyrosine kinase c‐kit is an independent prognostic factor in patients with small cell lung cancerInternational Journal of Cancer, 2004
- Therapy and outcome of small cell carcinoma of the kidneyCancer, 2003
- Small Cell Lung Carcinoma (SCLC)American Journal of Surgical Pathology, 2002
- Neuroendocrine Tumors of the Genital TractPathology Patterns Reviews, 2001
- Extrapulmonary small cell cancerClinical Oncology, 1995